Comparative Pharmacology
Head-to-head clinical analysis: ISMOTIC versus SORBITOL MANNITOL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ISMOTIC versus SORBITOL MANNITOL.
ISMOTIC vs SORBITOL-MANNITOL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Isosmotic solution of mannitol; increases plasma osmolality, drawing water from tissues into the vasculature and reducing intracranial/intraocular pressure via osmotic diuresis.
Sorbitol and mannitol are sugar alcohols that act as osmotic diuretics. They are filtered by the glomerulus but not reabsorbed, increasing osmotic pressure in the tubular lumen, thereby reducing water reabsorption and promoting diuresis. They also increase intraocular pressure and decrease intracranial pressure by drawing water from tissues into the bloodstream.
1-2 g orally every 6-8 hours, maximum 8 g/day; or 1-2 g intravenously over 5-10 minutes every 6-8 hours, maximum 8 g/day.
Osmotic diuretic; 50-100 g (as 25% solution) IV over 30-60 minutes, may repeat every 6-12 hours as needed; maximum 200 g/day.
None Documented
None Documented
4.5-6.0 hours in adults with normal renal function; prolonged in renal impairment (up to 24-48 hours in anuria)
Terminal elimination half-life is approximately 4-6 hours; may be prolonged in renal impairment.
Renal: 90-95% unchanged; biliary/fecal: <5%
Primarily renal excretion as unchanged drug; >90% eliminated via urine within 24 hours.
Category C
Category A/B
Osmotic Diuretic
Osmotic Diuretic